ERIC SILBERFEIN to Neoplasm Staging
This is a "connection" page, showing publications ERIC SILBERFEIN has written about Neoplasm Staging.
Connection Strength
0.343
-
Demographic and Clinicopathologic Factors of Patients With Hepatocellular Carcinoma in a Safety Net Hospital. J Surg Res. 2020 12; 256:374-380.
Score: 0.135
-
Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma. Clin Breast Cancer. 2010 Feb; 10(1):52-8.
Score: 0.065
-
Comparing barriers to early stage diagnosis of hepatocellular carcinoma between safety net hospitals and academic medical centers: An analysis from the United States Safety-Net Collaborative. J Surg Oncol. 2024 Sep; 130(3):493-503.
Score: 0.044
-
The Evolving Landscape of Hepatocellular Carcinoma : A US Safety Net Collaborative Analysis of Etiology of Cirrhosis. Am Surg. 2020 Jul; 86(7):865-872.
Score: 0.034
-
Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 2017 09; 162(3):557-567.
Score: 0.027
-
Pilot prognostic model of extremely poor survival among high-risk hepatocellular carcinoma patients. Cancer. 2012 Dec 15; 118(24):6118-25.
Score: 0.019
-
Relationship between documentation status and survival for medically underserved Hispanic breast cancer patients. J Surg Res. 2013 Apr; 180(2):284-9.
Score: 0.019